Circulating free tumor DNA in non-small cell lung cancer (NSCLC): clinical application and future perspectives

被引：42
|
作者：
Herbreteau, Guillaume [1 ]
Vallee, Audrey [1 ]
Charpentier, Sandrine [1 ]
Normanno, Nicola [2 ]
Hofman, Paul [3 ,4 ,5 ]
Denis, Marc G. [1 ]
机构：
[1] Nantes Univ Hosp, Dept Biochem, 9 Quai Moncousu, F-44093 Nantes, France
[2] Fdn G Pascale, IRCCS, Ist Nazl Tumori, Cell Biol & Biotherapy Unit, Naples, Italy
[3] Univ Cote Azur, CHU Nice, CNRS 7284, INSERM,Lab Clin & Expt Pathol,U1081, Nice, France
[4] Pasteur Hosp, FHU OncoAge, Nice, France
[5] Pasteur Hosp, Hosp Integrated Biobank BB 0033 00025, Nice, France
来源：
JOURNAL OF THORACIC DISEASE | 2019年 / 11卷
关键词：
Circulating tumor DNA (ctDNA); non-small cell lung cancer (NSCLC); EGFR mutation; ALK translocation; tumor mutation burden (TMB); minimal residual disease (MRD); MOLECULAR TESTING GUIDELINE; T790M RESISTANCE MUTATION; OF-AMERICAN-PATHOLOGISTS; EGFR MUTATION; LIQUID BIOPSY; ACQUIRED-RESISTANCE; ADENOCARCINOMA PATIENTS; CEREBROSPINAL-FLUID; ALK REARRANGEMENT; BRAF MUTATION;
D O I：
10.21037/jtd.2018.12.18
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Major advances in the treatment of non-small cell lung cancer (NSCLC) patients have been obtained during the last decade. Molecular testing of tumor samples is therefore mandatory in routine clinical practice. Tumor DNA is also present as cell-free molecules in blood, which is therefore a very useful and convenient source of tumor DNA. In this review, we discuss pre-analytical and analytical aspects of circulating tumor DNA (ctDNA) analysis. We also describe the use of ctDNA analysis in routine clinical practice, and discuss the potential use of ctDNA monitoring both to identify minimal residual disease and as a potential tool to early identify patients' response to treatment.
引用
收藏
页码：S113 / S126
页数：14
相关论文
共 50 条
  • [21] The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management
    Maria Gabriela O. Fernandes
    Natália Cruz-Martins
    José Carlos Machado
    José Luís Costa
    Venceslau Hespanhol
    Cancer Cell International, 21
  • [22] The clincial utility of circulating free DNA (cfDNA) analysis in non-small cell lung cancer (NSCLC) in the United Kingdom
    Greystoke, A.
    Carter, M.
    Griffiths, W.
    Laviste, G.
    Ortega-Franco, A.
    Rafee, S.
    Hannaway, N.
    Bridgewood, A.
    Hall, S.
    Blackhall, F. H.
    ANNALS OF ONCOLOGY, 2020, 31 : S859 - S859
  • [23] DNA repair pathways and non-small cell lung cancer: clinical perspectives
    Olaussen, Ken Andre
    Planchard, David
    Adam, Julien
    Soria, Jean-Charles
    BULLETIN DU CANCER, 2011, 98 (03) : 305 - 321
  • [24] Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer
    Chae, Young Kwang
    Davis, Andrew A.
    Agte, Sarita
    Pan, Alan
    Simon, Nicholas I.
    Iams, Wade T.
    Cruz, Marcelo R.
    Tamragouri, Keerthi
    Rhee, Kyunghoon
    Mohindra, Nisha
    Villaflor, Victoria
    Park, Wungki
    Lopes, Gilberto
    Giles, Francis J.
    ONCOLOGIST, 2019, 24 (06): : 820 - 828
  • [25] Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung Cancer
    Pellini, Bruna
    Szymanski, Jeffrey
    Chin, Re-, I
    Jones, Paul A.
    Chaudhuri, Aadel A.
    THORACIC SURGERY CLINICS, 2020, 30 (02) : 165 - +
  • [26] Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
    Peng, Muyun
    Huang, Qi
    Yin, Wei
    Tan, Sichuang
    Chen, Chen
    Liu, Wenliang
    Tang, Jingqun
    Wang, Xiang
    Zhang, Bingyu
    Zou, Min
    Li, Jina
    Su, Wenhui
    Wang, Lientu
    Chin, Lihan
    Yu, Fenglei
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [27] The expanding role of circulating tumor DNA in resectable non-small cell lung cancer
    Morgensztern, Daniel
    CANCER, 2024, 130 (10) : 1730 - 1732
  • [28] Circulating tumor DNA detection in advanced non-small cell lung cancer patients
    Guo, Zhi-Wei
    Li, Min
    Li, Ji-Qiang
    Zhou, Chun-Lian
    Zhai, Xiang-Ming
    Li, Ming
    Wu, Ying-Song
    Yang, Xue-Xi
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (05) : 878 - +
  • [29] Role of circulating-tumor DNA analysis in non-small cell lung cancer
    Jiang, Tao
    Ren, Shengxiang
    Zhou, Caicun
    LUNG CANCER, 2015, 90 (02) : 128 - 134
  • [30] Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer
    Yao, Yu
    Liu, Jinghao
    Li, Lei
    Yuan, Yuan
    Nan, Kejun
    Wu, Xin
    Zhang, Zhenyu
    Wu, Yi
    Li, Xin
    Zhu, Jiaqi
    Meng, Xuehong
    Wei, Longgang
    Chen, Jun
    Jiang, Zhi
    ONCOTARGET, 2017, 8 (02) : 2130 - 2140
12345